Allos Therapeutics 8K Departure of Directors or Certain Officers | ALTH 22 Oct 10

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.

Name and Title		Restricted Stock Units
Paul L. Berns President and Chief Executive Officer		265,734
Marc H. Graboyes Senior Vice President, General Counsel and Secretary		134,228
Bruce K. Bennett, Jr. Vice President, Pharmaceutical Operations		78,300
David C. Clark Vice President, Finance, Treasurer and Assistant Secretary		50,336

Allos Therapeutics (ALTH) Inactive 8-KDeparture of Directors or Certain Officers